The FDA proposed excluding the active ingredients in popular obesity and diabetes drugs from a list of substances that can be ...
Most of the infant formula in the U.S. is safe, but experts and health officials say regulators can take steps to make the ...
Psychedelics’ potential as a form of treatment is virtually unmatched. But their promise faces both scientific uncertainty ...
America is worried about fertility rates — again. Coverage of the country’s declining birth rate reflects widespread unease: ...
FDA review confirmed overall safety of 16 brands of baby formula. In a STAT Q&A, experts unpack what low-level PFAS findings ...
Efforts to make customized medicines at scale have hit commercial and regulatory roadblocks. Julia Vintarello is trying again ...
At the hearing, the judge heard from mothers who lost sons to overdose, a teenager born into withdrawal, and people who spent ...
J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized ...
Katherine Szarama, who joined the FDA last year to serve as Vinay Prasad’s deputy, will now fill his shoes at CBER.
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of ...
Why are investors excited about hair loss drugs? Will AI make clinical trials run more smoothly? And more in "The Readout ...
WASHINGTON — The Trump administration has dropped its nomination of Casey Means to be the next surgeon general, opting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results